New hope for dual struggle: ketamine therapy tested for alcohol and depression
NCT ID NCT07247370
Summary
This small, early-stage study is testing whether combining the medication ketamine with talk therapy is safe and helpful for people dealing with both alcohol use disorder and major depression. Twenty participants will receive ketamine doses alongside cognitive-behavioral therapy over six weeks. The main goals are to see if the approach is practical to deliver and to look for early signs it might reduce drinking and ease depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Drug Health Services, Royal Prince Alfred Hospital
Sydney, New South Wales, 2050, Australia
Contact Phone: •••-•••-••••
Contact Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.